Comparative effectiveness of tenofovir in treatment-naïve HIV-infected patients: systematic review and meta-analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative effectiveness of tenofovir in treatment-naïve HIV-infected patients: systematic review and meta-analysis
Authors
Keywords
-
Journal
HIV CLINICAL TRIALS
Volume 16, Issue 5, Pages 178-189
Publisher
Informa UK Limited
Online
2015-09-23
DOI
10.1179/1945577115y.0000000004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of Cardiovascular Events Associated With Current Exposure to HIV Antiretroviral Therapies in a US Veteran Population
- (2015) Manisha Desai et al. CLINICAL INFECTIOUS DISEASES
- HIV infection and cardiovascular disease
- (2014) L. G. Hemkens et al. EUROPEAN HEART JOURNAL
- Virological efficacy of abacavir: systematic review and meta-analysis
- (2014) M. Cruciani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Reducing waste from incomplete or unusable reports of biomedical research
- (2014) Paul Glasziou et al. LANCET
- Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial
- (2014) François Raffi et al. LANCET
- The RADAR Study: Week 48 Safety and Efficacy of RAltegravir Combined with Boosted DARunavir Compared to Tenofovir/Emtricitabine Combined with Boosted Darunavir in Antiretroviral-Naive Patients. Impact on Bone Health
- (2014) Roger J. Bedimo et al. PLoS One
- Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1
- (2013) Eric S. Daar ANNALS OF INTERNAL MEDICINE
- A randomized clinical trial comparing metabolic parameters after 48 weeks of standard- and low-dose stavudine therapy and tenofovir disoproxil fumarate therapy in HIV-infected South African patients
- (2013) CN Menezes et al. HIV MEDICINE
- Abacavir/Lamivudine versus Tenofovir/Emtricitabine with Atazanavir/Ritonavir for Treatment-naive Japanese Patients with HIV-1 Infection: A Randomized Multicenter Trial
- (2013) Takeshi Nishijima et al. INTERNAL MEDICINE
- Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
- (2013) Sharon L. Walmsley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents
- (2012) Roger Bedimo et al. AIDS
- A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine
- (2012) Nittaya Phanuphak et al. ANTIVIRAL THERAPY
- Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis
- (2012) Fakhrul M Islam et al. BMC PUBLIC HEALTH
- The early effects of stavudine compared with tenofovir on adipocyte gene expression, mitochondrial DNA copy number and metabolic parameters in South African HIV-infected patients: a randomized trial
- (2012) CN Menezes et al. HIV MEDICINE
- Maraviroc Once-Daily Nucleoside Analog-Sparing Regimen in Treatment-Naive Patients
- (2012) Anthony Mills et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings
- (2012) Thomas B. Campbell et al. PLOS MEDICINE
- Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons
- (2011) Andy I Choi et al. AIDS
- Incidence of low and high-energy fractures in persons with and without HIV infection
- (2011) Ann-Brit E. Hansen et al. AIDS
- Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s
- (2011) G. A. McComsey et al. CLINICAL INFECTIOUS DISEASES
- Examination of Noninferiority, Safety, and Tolerability of Lopinavir/ritonavir and Raltegravir Compared with Lopinavir/ritonavir and Tenofovir/ Emtricitabine in Antiretroviral-Naïve Subjects: The PROGRESS Study, 48-Week Results
- (2011) Jacques Reynes et al. HIV CLINICAL TRIALS
- Abacavir/Lamivudine Versus Tenofovir DF/Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results
- (2011) Paul E. Sax et al. JOURNAL OF INFECTIOUS DISEASES
- Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
- (2011) Grace A. McComsey et al. JOURNAL OF INFECTIOUS DISEASES
- Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study
- (2010) Hans‐Jürgen Stellbrink et al. CLINICAL INFECTIOUS DISEASES
- Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients
- (2010) Ryan D. Cooper et al. CLINICAL INFECTIOUS DISEASES
- Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites
- (2010) WH Belloso et al. HIV MEDICINE
- Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, HIV-1–Infected Adults: 48-Week Results From the ASSERT Study
- (2010) Frank A Post et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment
- (2009) Kimberly Y Smith et al. AIDS
- Simplification of Antiretroviral Therapy with Tenofovir‐Emtricitabine or Abacavir‐Lamivudine: A Randomized, 96‐Week Trial
- (2009) Allison Martin et al. CLINICAL INFECTIOUS DISEASES
- Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients
- (2009) Jose R Arribas et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
- (2009) Paul E. Sax et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand
- (2008) Gail V. Matthews et al. HEPATOLOGY
- Reasons or excuses for avoiding meta-analysis in forest plots
- (2008) John P A Ioannidis et al. BMJ-British Medical Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started